Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells.
Lipreri da Silva JC, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WFD, Velloso EDRP, Bendit I, Costa-Lotufo LV, Rego EM, Ridley AJ, Machado-Neto JA. Lipreri da Silva JC, et al. Among authors: vicari hp. Eur J Pharmacol. 2025 Jan 15;987:177161. doi: 10.1016/j.ejphar.2024.177161. Epub 2024 Nov 29. Eur J Pharmacol. 2025. PMID: 39615869
Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents.
Carvalho MFL, de Almeida BO, Bueno MLP, Vicari HP, Lima K, Rego EM, Roversi FM, Machado-Neto JA. Carvalho MFL, et al. Among authors: vicari hp. Hematol Transfus Cell Ther. 2024 Jul-Sep;46(3):273-282. doi: 10.1016/j.htct.2023.11.007. Epub 2023 Dec 31. Hematol Transfus Cell Ther. 2024. PMID: 38326180 Free PMC article.
ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia.
Lipreri da Silva JC, Coelho-Silva JL, Vicari HP, Lima K, Rego EM, Traina F, Machado-Neto JA. Lipreri da Silva JC, et al. Among authors: vicari hp. Hematol Transfus Cell Ther. 2024 Jan-Mar;46(1):101-105. doi: 10.1016/j.htct.2023.06.004. Epub 2023 Jul 31. Hematol Transfus Cell Ther. 2024. PMID: 37541806 Free PMC article. No abstract available.
Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia.
Lipreri da Silva JC, Saldanha-Araujo F, de Melo RCB, Vicari HP, Silva-Carvalho AE, Rego EM, Buccheri V, Machado-Neto JA. Lipreri da Silva JC, et al. Among authors: vicari hp. Life Sci. 2022 Dec 15;311(Pt B):121146. doi: 10.1016/j.lfs.2022.121146. Epub 2022 Nov 3. Life Sci. 2022. PMID: 36336127 Free article.
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.
Vicari HP, Coelho-Silva JL, Pereira-Martins DA, Lucena-Araujo AR, Lima K, Lipreri da Silva JC, Scheucher PS, Koury LC, de Melo RA, Bittencourt R, Pagnano K, Nunes E, Fagundes EM, Kerbauy F, de Figueiredo-Pontes LL, Costa-Lotufo LV, Rego EM, Traina F, Machado-Neto JA. Vicari HP, et al. Invest New Drugs. 2022 Apr;40(2):438-452. doi: 10.1007/s10637-021-01197-0. Epub 2021 Nov 27. Invest New Drugs. 2022. PMID: 34837603
14 results